trial · primary record
Atezolizumab
Lung Non-Small Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 417 |
| Primary completion | 2027-06-09 |
| Primary endpoint | Overall Survival |
| Registry ID | NCT04214262 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:18.048Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04214262
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.